Clinical Trials

Carcinoma, Non-Small-Cell Lung

NCT03101995 2025-05-28

Assessment of Gemcitabine as Chemoradiotherapy in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease

Phase 2 Recruiting

18 enrolled

Uterine Cervical Neoplasms, Renal Insufficiency

NCT06156514 2025-05-28

MICHELE

Phase 3 Recruiting

140 enrolled

Phase 2 Active not recruiting

Locally Advanced Cervical Cancer

NCT06531447 2024-08-01

First-line Gemcitabine Plus Cisplatin in Locally Advanced (IIIC Stage) Breast Cancer Patients

200 enrolled

Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement, Breast Neoplasms

NCT02707159 2023-03-08

PACT-ACT-v6

70 enrolled

Neoplastic Cells, Circulating, Pancreatic Neoplasms

NCT01003964 2022-04-12

Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IV

289 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02778308 2021-04-06

Adjuvant Chemotherapy vs no Chemotherapy for Patients With GallBllader Carcinoma

Phase NA Completed

100 enrolled

Gallbladder Neoplasms

NCT02860819 2021-03-03

Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer

15 enrolled

Genitourinary

Testicular Neoplasms

NCT01043172 2018-01-03

A Study of Gemcitabine as an Adjuvant Treatment for Cholangiocarcinoma After Surgical Resection

72 enrolled

Cholangiocarcinoma

NCT01939418 2017-10-03

Phase Ib/II Trials of RAD001 in Triple Negative Metastatic Breast Cancer

Phase 1/2 Terminated

23 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02957266 2016-11-15

CERVIPIB

Phase 3 Unknown

400 enrolled

Uterine Cervical Neoplasms

NCT00280878 2016-01-15

Rituximab in Combination With Outpatient Therapy for CD20+ Lymphoma

12 enrolled

Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin

NCT00163748 2016-01-08

Efficacy and Treatment Related Toxicity Study of a New Regimen for Lymphoma

40 enrolled

Lymphoid

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin

NCT00163761 2016-01-08

Efficacy Study of Outpatient Therapy for Lymphoma

90 enrolled

Lymphoid

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin

NCT02095119 2015-04-14

A Monoclonal Antibody, Nimotuzumab, as Treatment for Recurrent or Metastatic Cervical Cancer

Phase 1/2 Completed

15 enrolled

Uterine Cervical Neoplasms

NCT00697905 2014-11-21

Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma

18 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT00636883 2014-01-22

GEMOX-T

Phase 2 Terminated

9 enrolled

Pancreatic Neoplasms

NCT01356368 2014-01-22

Customizing

Phase 2 Terminated

3 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00532857 2012-01-04

PGH

53 enrolled

Breast Neoplasms

NCT01133912 2012-01-04

PGT

Phase 1 Completed

13 enrolled

Breast Neoplasms

NCT00532623 2011-06-27

Phase II Study of Gemcitabine/Vinorelbine vs Sequential Gemcitabine Followed by Vinorelbine in Metastatic Breast Cancer

82 enrolled

Breast Neoplasms

NCT00532285 2011-06-23

Primary Paclitaxel Plus Gemcitabine in Patients With Stage II and III Breast Cancer

Phase 2 Terminated

44 enrolled

Breast Neoplasms

NCT00452881 2010-10-25

Adjuvant Gemcitabine Plus Oxaliplatin Versus Gemcitabine Plus Cisplatin for Completely Resected Stage IB/II/IIIA NSCLC

Phase 2 Unknown

151 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00453115 2010-10-25

Gemcitabine Plus Oxaliplatin in Advanced Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

Phase 2 Unknown

43 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00453167 2010-07-12

Weekly Paclitaxel Plus Gemcitabine as Second-line in Small Cell Lung Cancer

35 enrolled

Lung Neoplasms, Small Cell Lung Carcinoma

NCT00563160 2010-07-07

Study of Efficacy of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small-cell Lung Cancer Before Surgery

Phase 2 Unknown

50 enrolled

Lung Neoplasms

NCT00486460 2007-06-14

Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer

Phase 3 Unknown